Searched for
FLUCONAZOLE TABLETS
Are fundamental tailwinds a stronger play than volatile markets? 6 mid-cap pharma stocks with an upside potential of over 22%The Indian pharmaceutical sector has undergone significant changes over the past decade, marking a transition from a period of consolidatio...- Mid-cap pharma space: Risk & opportunity are two sides of the same coin. 7 pharma stocks with upside potential of up to 41%Two things increase the probability of a sector becoming the next big sector in India. One: As a country, India should have some edge in th...
- Volatile phases come and go, structural tailwinds are a stronger play: 5 Indian pharma stocks with upside potential of up to 35%There are some sectors which have witnessed something which can be called “second inning”. Which is that in the last two decades, they did ...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 34%Given the way indices and broader markets have panned out, it is very likely that we are going to soon see the market hitting new highs. Th...
- Lupin gets USFDA nod to market generic antifungal tabletsThe approval granted by the US Food and Drug Administration (USFDA) for the abbreviated new drug application of Fluconazole tablets in stre...
- After a long winter finally some tailwinds; 6 pharma stocks with upside potential of up to 31%While all pharma companies get classified into one sector they are very different at molecular level. Each company has its own operating ma...
- A Healthy Dose! 4 midcap pharma stocks with upside potential of up to 36%After a long period of under performance, pharma stocks have seen interest coming back from institutional investors. This is because some t...
- Finally out of the woods? 4 midcap pharma stocks with an upside potential up to 34 %Pharma stocks had been underperforming for a very long time. Some time USFDA issues, at other instances of pricing pressure in US markets h...
- On a path to recovery: 5 midcap pharma stocks with an upside potential up to 32%As the markets get jittery, select pharma stocks are back in focus. This tends to happen in volatile markets. Some of them are mid-sized In...
- Midcaps with long term perspective; 9 stocks with high ROE & net profit marginMany investors, especially the ones sitting on cash are confused about what they should do with their existing stocks – buy the dip or not....
- Zydus gets USFDA nod for fungal infections, skin disorder drugThe company has received final approval from the USFDA to market Fluconazole tablets USP and Clobetasol Propionate Spray
- Zydus Cadila receives USFDA nod to market fluconazole tabletsThe company also received approval for Clobetasol Propionate spray used in the treatment of various skin disorders.
- Blood pressure drugs and antibiotics to be cheaper as government plans to notify price capsTop-selling blood pressure drugs and antibiotics could become a lot cheaper as the govt plans to notify price caps for 51 essential drugs
- Bafna Pharma gets Ghana's approval for hypertension drugBafna Pharmaceuticals on Wednesday said it has received Ghana health regulator's approval to sell Atenolol tablets, used in the treatment o...
- Aurobindo Pharma gets USFDA nod for two drugsAurobindo Pharma on Friday said it has received approval from the US drug regulator for manufacturing and marketing two drugs - Cyclobenzap...
Load More
